See more : United Communications Partners Inc. (UCPA) Income Statement Analysis – Financial Results
Complete financial analysis of Magellan Health, Inc. (MGLN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Magellan Health, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
- Hexa Tradex Limited (HEXATRADEX.NS) Income Statement Analysis – Financial Results
- Jai Balaji Industries Limited (JAIBALAJI.NS) Income Statement Analysis – Financial Results
- Leviathan Gold Ltd. (LVXFF) Income Statement Analysis – Financial Results
- AXIOS Sustainable Growth Acquis (AXAC-RI) Income Statement Analysis – Financial Results
- Bulten AB (publ) (BULTEN.ST) Income Statement Analysis – Financial Results
Magellan Health, Inc. (MGLN)
About Magellan Health, Inc.
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.58B | 7.16B | 7.31B | 5.84B | 4.84B | 4.60B | 3.76B | 3.55B | 3.21B | 2.80B | 2.97B | 2.64B | 2.63B | 2.16B | 1.69B | 1.81B | 1.80B | 1.51B | 445.89M | 1.76B | 1.87B | 1.87B | 1.51B | 1.21B | 1.35B | 1.15B | 904.65M |
| Cost of Revenue | 4.46B | 6.93B | 7.12B | 5.57B | 4.58B | 4.42B | 3.55B | 3.31B | 2.96B | 2.02B | 2.13B | 2.43B | 2.44B | 1.96B | 1.51B | 1.57B | 0.00 | 1.32B | 0.00 | 1.56B | 1.65B | 1.66B | 1.29B | 978.51M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 118.79M | 229.29M | 197.18M | 271.02M | 258.94M | 178.38M | 215.08M | 238.19M | 249.58M | 782.64M | 842.63M | 207.46M | 186.87M | 193.26M | 181.90M | 241.62M | 1.80B | 185.86M | 445.89M | 198.47M | 220.97M | 208.01M | 217.97M | 232.18M | 1.35B | 1.15B | 904.65M |
| Gross Profit Ratio | 2.60% | 3.20% | 2.70% | 4.64% | 5.35% | 3.88% | 5.72% | 6.72% | 7.78% | 27.96% | 28.38% | 7.85% | 7.12% | 8.96% | 10.76% | 13.36% | 100.00% | 12.30% | 100.00% | 11.31% | 11.79% | 11.11% | 14.41% | 19.18% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.59B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 876.61M | 822.39M | 723.50M | 619.55M | 557.51M | 529.63M | 566.58M | 0.00 | 0.00 | 0.00 | 0.00 | 15.81M | 1.59B | 0.00 | 391.43M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 98.39M | 131.51M | 132.66M | 115.71M | -770.57M | -719.55M | -632.43M | -547.55M | -497.02M | 58.62M | 54.68M | 47.27M | 60.81M | 57.52M | 48.86M | 49.09M | 42.49M | 358.06M | 14.38M | 35.07M | 91.02M | 63.79M | 103.54M | 163.71M | 1.23B | 1.15B | 922.79M |
| Operating Expenses | 98.39M | 131.51M | 132.66M | 115.71M | 106.05M | 102.84M | 91.07M | 71.99M | 60.49M | 588.26M | 621.26M | 47.27M | 60.81M | 57.52M | 48.86M | 64.90M | 1.63B | 358.06M | 405.81M | 35.07M | 91.02M | 63.79M | 103.54M | 163.71M | 1.23B | 1.15B | 922.79M |
| Cost & Expenses | 4.56B | 7.06B | 7.25B | 5.68B | 4.68B | 4.52B | 3.64B | 3.38B | 3.02B | 2.61B | 2.75B | 2.48B | 2.50B | 2.02B | 1.56B | 1.63B | 1.63B | 1.68B | 405.81M | 1.59B | 1.74B | 1.73B | 1.40B | 1.14B | 1.23B | 1.15B | 922.79M |
| Interest Income | 4.05M | 19.19M | 14.07M | 5.89M | 2.82M | 2.17M | 1.30M | 1.99M | 2.02M | 2.78M | 3.28M | 6.25M | 17.03M | 23.84M | 17.63M | 17.46M | 6.13M | 2.87M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 30.87M | 36.15M | 35.40M | 25.98M | 10.19M | 6.58M | 7.39M | 3.00M | 2.25M | 2.50M | 2.23M | 2.42M | 2.85M | 6.39M | 7.29M | 44.01M | 37.12M | 61.02M | 873.00K | -8.80M | -83.00M | -18.41M | -38.31M | -14.36M | -6.16M | 0.00 | -12.62M |
| Depreciation & Amortization | 118.75M | 131.51M | 132.66M | 115.71M | 106.05M | 102.84M | 91.07M | 71.99M | 60.49M | 58.62M | 54.68M | 47.27M | 60.81M | 57.52M | 48.86M | 49.09M | 42.49M | 48.05M | 14.38M | 70.28M | 79.24M | 73.53M | 54.89M | 44.86M | 48.92M | 64.09M | 59.55M |
| EBITDA | 487.41M | 248.48M | 211.25M | 276.97M | 263.85M | 183.25M | 221.55M | 240.18M | 251.60M | 255.79M | 279.32M | 213.70M | 203.90M | 216.74M | 205.11M | 306.09M | 214.57M | 594.65M | 29.24M | 131.22M | 28.91M | 105.60M | 55.64M | 53.60M | 107.00M | 9.82M | -10.60M |
| EBITDA Ratio | 10.65% | 3.47% | 2.89% | 4.74% | 5.45% | 3.99% | 5.89% | 6.77% | 7.84% | 9.14% | 9.41% | 8.09% | 7.77% | 10.05% | 12.13% | 16.93% | 11.95% | 39.36% | 6.56% | 7.47% | 1.54% | 5.64% | 3.68% | 4.43% | 7.95% | 0.85% | -1.17% |
| Operating Income | 368.67M | 116.97M | 78.59M | 161.27M | 157.80M | 80.40M | 130.48M | 168.19M | 191.11M | 197.16M | 224.64M | 166.43M | 143.09M | 159.21M | 156.25M | 257.00M | 172.08M | 546.60M | 14.86M | 60.94M | -50.33M | 32.06M | 750.00K | 8.74M | 58.08M | -54.27M | -70.16M |
| Operating Income Ratio | 8.05% | 1.63% | 1.07% | 2.76% | 3.26% | 1.75% | 3.47% | 4.74% | 5.96% | 7.04% | 7.57% | 6.30% | 5.45% | 7.38% | 9.24% | 14.21% | 9.58% | 36.18% | 3.33% | 3.47% | -2.69% | 1.71% | 0.05% | 0.72% | 4.32% | -4.71% | -7.75% |
| Total Other Income/Expenses | -409.15M | -36.15M | -35.40M | -26.04M | -12.28M | -9.29M | -12.56M | -3.00M | -2.25M | -2.50M | -2.23M | -2.42M | -2.85M | -6.03M | -7.33M | -45.54M | -40.54M | -60.82M | -873.00K | 8.80M | 83.00M | 18.41M | 38.31M | 14.36M | 6.16M | 0.00 | 12.62M |
| Income Before Tax | -40.49M | 80.82M | 43.19M | 135.22M | 145.52M | 71.12M | 117.92M | 165.19M | 188.87M | 194.66M | 222.40M | 164.01M | 140.24M | 153.19M | 148.92M | 211.46M | 131.54M | 485.78M | 13.99M | 69.74M | 32.67M | 50.47M | 39.06M | 23.10M | 64.24M | -54.27M | -57.54M |
| Income Before Tax Ratio | -0.88% | 1.13% | 0.59% | 2.32% | 3.01% | 1.55% | 3.14% | 4.66% | 5.89% | 6.95% | 7.49% | 6.21% | 5.34% | 7.11% | 8.81% | 11.70% | 7.33% | 32.16% | 3.14% | 3.97% | 1.74% | 2.70% | 2.58% | 1.91% | 4.78% | -4.71% | -6.36% |
| Income Tax Expense | -44.53M | 24.92M | 19.01M | 25.08M | 69.73M | 42.41M | 43.69M | 39.92M | 37.84M | 65.04M | 83.74M | 57.34M | 54.04M | 58.67M | 62.70M | 82.41M | 46.58M | 33.81M | 3.13M | 36.39M | 15.48M | 27.38M | 20.03M | 9.24M | 25.70M | -11.31M | -10.54M |
| Net Income | 4.05M | 55.90M | 24.18M | 110.14M | 75.79M | 28.71M | 74.23M | 125.26M | 151.03M | 129.62M | 138.66M | 106.67M | 86.21M | 94.52M | 86.22M | 129.05M | 84.95M | 451.97M | 10.86M | 33.35M | 17.19M | 23.10M | 19.03M | 13.86M | 38.54M | -42.96M | -47.00M |
| Net Income Ratio | 0.09% | 0.78% | 0.33% | 1.89% | 1.57% | 0.62% | 1.97% | 3.53% | 4.71% | 4.63% | 4.67% | 4.04% | 3.28% | 4.38% | 5.10% | 7.14% | 4.73% | 29.92% | 2.43% | 1.90% | 0.92% | 1.23% | 1.26% | 1.14% | 2.87% | -3.73% | -5.20% |
| EPS | 0.16 | 2.28 | 0.97 | 4.72 | 3.27 | 1.15 | 2.78 | 4.63 | 5.51 | 4.25 | 4.10 | 3.03 | 2.18 | 2.43 | 2.33 | 3.59 | 2.40 | 12.80 | 0.31 | 1.00 | 0.53 | 0.73 | 0.62 | 0.47 | 1.24 | -1.54 | -1.78 |
| EPS Diluted | 0.16 | 2.28 | 0.97 | 4.51 | 3.14 | 1.11 | 2.71 | 4.53 | 5.42 | 4.17 | 4.03 | 3.01 | 2.16 | 2.37 | 2.23 | 3.42 | 2.34 | 10.86 | 0.26 | 0.81 | 0.53 | 0.72 | 0.61 | 0.46 | 1.24 | -1.54 | -1.78 |
| Weighted Avg Shares Out | 25.78M | 24.56M | 25.04M | 23.33M | 23.18M | 24.87M | 26.69M | 27.05M | 27.39M | 30.48M | 33.78M | 35.25M | 39.61M | 38.94M | 36.99M | 35.97M | 35.37M | 35.31M | 35.14M | 33.45M | 32.14M | 31.76M | 30.78M | 29.47M | 31.01M | 27.87M | 26.39M |
| Weighted Avg Shares Out (Dil) | 25.78M | 24.56M | 25.04M | 24.44M | 24.16M | 25.88M | 27.36M | 27.68M | 27.88M | 31.06M | 34.44M | 35.42M | 40.00M | 39.84M | 38.62M | 37.69M | 36.36M | 41.61M | 41.44M | 41.24M | 32.39M | 31.92M | 31.20M | 30.17M | 31.01M | 27.87M | 26.39M |
Magellan Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Magellan Health, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – MGLN
Magellan Health climbs after agreeing to Centene buyout offer
Centene Signs Definitive Agreement to Acquire Magellan Health
Here's Why Hold Strategy is Apt for Magellan (MGLN) Stock
Magellan Health (MGLN) Buys Bayless to Aid Behavioral Health
Magellan Health Announces Acquisition of Majority Interest in Bayless Integrated Healthcare
4 Healthcare Stocks to Take Care of in 2021 to Boost Portfolio
Recap: Magellan Health Q3 Earnings
Magellan Health Reports Third Quarter 2020 Financial Results
Q3 2020 Earnings Estimate for Magellan Midstream Partners, L.P. (NYSE:MMP) Issued By Jefferies Financial Group
Source: https://incomestatements.info
Category: Stock Reports